Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool... see more

TSXV:CVM.H - Post Discussion

CVR Medical Corp > This is what happened
View:
Post by Looneytunes on Nov 09, 2022 3:41pm

This is what happened

CVR MEDICAL CORP. ("CVM.H") [formerly CVR Medical Corp. ("CVM")] BULLETIN TYPE: Transfer and New Addition to NEX, Symbol Change, Remain Suspended BULLETIN DATE: September 29, 2022 TSX Venture Tier 2 Company In accordance with TSX Venture Policy 2.5, the Company has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on Monday, October 3, 2022, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Vancouver to NEX. As of October 3, 2022, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from CVM to CVM.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the Exchange bulletin issued May 9, 2022, trading in the shares of the Company will remain suspended. Members are prohibited from trading in the securities of the Company during the period of the suspension or until further notice. ______________________________
Comment by Abovenbeyond on Nov 09, 2022 4:23pm
Wow
Comment by Abovenbeyond on Nov 09, 2022 5:02pm
So now what?
Comment by Looneytunes on Nov 10, 2022 5:57pm
The way I'm reading it is that all we can do is wait to see whether Blunden and co can actually get the CSS through its trials and submitted to the FDA. Even though we can't trade them, our shares do still exist so we have to hope that at some point they relist on the TSX and they become worth something again. All just a waiting game now, will need to do some research on whether companies ...more  
Comment by Abovenbeyond on Nov 10, 2022 7:39pm
Glad you have some info to share. Thanks
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities